EGFR and colorectal cancer: Meanwhile, a phase 1 study was launched to test the efficacy of combining sotorasib with the EGFR inhibitor panitumumab in treating chemotherapy-resistant colorectal cancer, which confirmed its safety and efficacy (NCT04185883) [317].